# Metabolic Changes in Prostate Cancer Patients With Androgen-ablation Therapy (AAT)

> **NCT01284608** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 197 (actual)

## Conditions studied

- Prostatic Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01284608
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 197 (ACTUAL)
- **Last updated:** 2012-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01284608

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01284608, "Metabolic Changes in Prostate Cancer Patients With Androgen-ablation Therapy (AAT)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01284608. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*